摘要
目的评估450 nm蓝激光半导体治疗机6点位置定位法治疗中叶增生型良性前列腺增生(BPH)的疗效及安全性,以期推广该术式的临床应用。方法回顾性分析2023年3月—8月在泰安市中心医院迎胜院区泌尿肾病激光治疗中心行450 nm蓝激光半导体治疗机6点位置定位法治疗20例中叶增生型BPH患者的临床资料,记录手术时间、术后膀胱冲洗时间、尿管留置时间、术后住院时间、手术并发症。比较患者术前及术后1个月最大尿流率(Qmax)、膀胱残余尿量(PVR)、生活质量评分(QoL)、国际前列腺症状评分(IPSS)变化情况。结果本组患者手术时间为(26.80±7.22)min,术后膀胱冲洗时间为(20.50±1.79)h,所有患者术后次日拔除导尿管,术后2 d顺利出院。与术前比较,患者术后1个月的Qmax显著升高[(7.40±1.05)mL/s vs.(19.60±1.76)mL/s]、PVR[(73.50±12.26)mL vs.(9.25±4.94)mL]、QoL[(4.55±1.19)分vs.(1.95±0.95)分]、IPSS[(26.55±1.88)分vs.(10.05±1.36)分]均显著降低,差异具有统计学意义(P<0.05)。术中及术后1个月随访期间无任何并发症发生。结论450 nm蓝激光半导体治疗机6点位置定位法治疗中叶增生型BPH是一种新型、安全、有效的手术方式,值得在临床推广应用。
Objective To investigate the efficacy and safety of 450 nm blue laser with 6 o'clock positioning in the treatment of middle lobe hyperplasia of prostate,in order to promote the clinical application of this surgery.Methods Clinical data of 20 patients with middle lobe hyperplasia of prostate treated with 450 nm blue laser with 6 o'clock positioning during Mar.and Aug.2023 were retrospectively analyzed.The operation time,postoperative bladder irrigation time,catheter indwelling time,hospital stay,and complications were recorded.The maximum urinary flow rate(Qmax),post-void residual volume(PVR),quality of life scale(QoL),international prostate symptom score(IPSS)before surgery and 1 month after surgery were compared.Results The operation time was(26.80±7.22)min,and bladder irrigation time was(20.50±1.79)h.The catheter was removed on the next day after surgery and all patients were discharged 2 days after operation.Compared to preoperative,one month after surgery,the Qmax[(7.40±1.05)mL/s vs.(19.60±1.76)mL/s]was significantly higher,PVR[(73.50±12.26)mL vs.(9.25±4.94)mL],QoL[(4.55±1.19)vs.(1.95±0.95)],and IPSS[(26.55±1.88)vs.(10.05±1.36)]were significantly lower,the differences being statistically significant(P<0.05).No complications occurred during operation and 1-month follow-up.Conclusion The 450 nm blue laser with 6 o'clock positioning is a new,safe and effective surgical treatment of middle lobe hyperplasia of prostate,which is worthy of clinical promotion and application.
作者
屠凡倬
郝晓航
胡燕
胡遵杰
李松
高文举
刘飞
王昊星
赵永伟
TU Fanzhuo;HAO Xiaohang;HU Yan;HU Zunjie;Li Song;GAO Wenju;LIU Fei;WANG Haoxing;ZHAO Yongwei(Urinary Nephropathy Laser Treatment Center,Yingsheng Branch of Taian Central Hospital,Taian 271000;Department of Urology,Huaihe Hospital,Henan University,Kaifeng 475000,China)
出处
《现代泌尿外科杂志》
CAS
2024年第4期320-323,共4页
Journal of Modern Urology
